TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis
Authors
Keywords
TDP-43, Amyotrophic lateral sclerosis, Biomarker, Systematic review, Meta-analysis
Journal
BMC Neurology
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1186/s12883-018-1091-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer’s Disease
- (2017) Stephanie M. Williams et al. JOURNAL OF ALZHEIMERS DISEASE
- Genetic epidemiology of motor neuron disease-associated variants in the Scottish population
- (2017) Holly A. Black et al. NEUROBIOLOGY OF AGING
- Frontotemporal Dementia
- (2017) Nicholas T. Olney et al. NEUROLOGIC CLINICS
- Care management in amyotrophic lateral sclerosis
- (2017) M.-H. Soriani et al. REVUE NEUROLOGIQUE
- ALS and frontotemporal dementia belong to a common disease spectrum
- (2017) P. Couratier et al. REVUE NEUROLOGIQUE
- Genetics of Frontotemporal Dementia
- (2016) Diana A. Olszewska et al. Current Neurology and Neuroscience Reports
- Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study
- (2016) H. Bea Kuiperij et al. JOURNAL OF ALZHEIMERS DISEASE
- Therapy and clinical trials in frontotemporal dementia: past, present, and future
- (2016) Richard M. Tsai et al. JOURNAL OF NEUROCHEMISTRY
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis
- (2013) Susan Byrne et al. ANNALS OF NEUROLOGY
- Differential diagnosis of amyotrophic lateral sclerosis from Guillain–Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid
- (2013) Masato Hosokawa et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Familial clustering of ALS in a population-based resource
- (2013) S. B. Gibson et al. NEUROLOGY
- Advances in understanding the molecular basis of frontotemporal dementia
- (2012) Rosa Rademakers et al. Nature Reviews Neurology
- Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value
- (2010) Yu-Ichi Noto et al. Amyotrophic Lateral Sclerosis
- Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2008) Takashi Kasai et al. ACTA NEUROPATHOLOGICA
- TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
- (2008) Penelope Foulds et al. ACTA NEUROPATHOLOGICA
- TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
- (2008) Petra Steinacker et al. ARCHIVES OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More